• Kenvue Inc. has reported past first-quarter 2026 results showing sales of US$3,909 million and net income of US$474 million, with basic and diluted earnings per share from continuing operations of US$0.25, all higher than the prior-year period.
• This profit improvement has coincided with Kenvue’s addition to a Zacks Rank #1 (Strong Buy) list and increased analyst attention on its earnings outlook, amid ongoing legal and leadership changes.
• With stronger recent earnings now public, we’ll examine how this performance shift could influence Kenvue’s existing investment narrative and future assumptions.

Outshine the giants: these 15 early-stage AI stocks could fund your retirement.

Kenvue Investment Narrative Recap

To own Kenvue, you need to believe in the durability of its consumer health brands and its ability to translate them into dependable earnings, even as the company simplifies operations and upgrades digital capabilities. The latest quarter’s higher sales and net income support the near term earnings story, but they do not remove the central risk around leadership turnover and the company’s broader strategic reset, which could still introduce volatility into execution and short term performance.

The most connected update here is Kenvue’s addition to the Zacks Rank #1 (Strong Buy) list, following an upward revision in consensus earnings estimates. That ranking reflects how some analysts have reframed Kenvue’s earnings outlook after recent results, which ties directly into the key catalyst of improving profitability and better capital allocation, while sitting alongside concerns about governance shifts and ongoing legal exposure around brands such as Tylenol.

Yet behind the stronger quarter and upgraded rankings, investors still need to be aware of the unresolved legal risk around Tylenol marketing and how it could...

Kenvue's narrative projects $16.6 billion revenue and $2.2 billion earnings by 2029. This requires 2.7% yearly revenue growth and an earnings increase of about $0.6 billion from $1.6 billion today.

Uncover how Kenvue's forecasts yield a $19.58 fair value, a 12% upside to its current price.

Exploring Other Perspectives

Four members of the Simply Wall St Community currently see Kenvue’s fair value between US$19 and about US$29.79, reflecting a wide range of price expectations. Against that backdrop, the company’s leadership changes and ongoing strategic review highlight why you may want to weigh multiple viewpoints on how reliably Kenvue can execute its simplification and digital growth plans.

Explore 4 other fair value estimates on Kenvue - why the stock might be worth just $19.00!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Kenvue research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Kenvue research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Kenvue's overall financial health at a glance.

Ready To Venture Into Other Investment Styles?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

• Uncover the next big thing with 27 elite penny stocks that balance risk and reward.
• Find 44 companies with promising cash flow potential yet trading below their fair value.
• Capitalize on the AI infrastructure supercycle with our selection of the 38 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.